Instruct: Given a scientific paper title, retrieve paper titles that are cited by the given paper.
Query: Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation
Adjunctive Taurine in First-Episode Psychosis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study.
smartphone cognitive behavioral therapy as an adjunct to pharmacotherapy for refractory depression : randomized controlled trial .
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia.
Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis
Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double-blind, placebo-controlled trial.
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
Comparative Effectiveness of Clozapine and Standard Antipsychotic Treatment in Adults With Schizophrenia
Subcallosal cingulate deep brain stimulation for treatment-resistant depression: a multisite, randomised, sham-controlled trial
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
Feasibility Randomized Controlled Trial of Cognitive and Behavioral Interventions for Depression Symptoms in Patients Accessing Drug and Alcohol Treatment
Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options
Stimulant and other substance use disorders in schizophrenia: Prevalence, correlates and impacts in a population sample
Music therapy for people with schizophrenia and schizophrenia-like disorders
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
d-Serine Added to Clozapine for the Treatment of Schizophrenia
An efficient user verification system via mouse movements
The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis
Cloning credit cards: a combined pre-play and downgrade attack on EMV contactless
Implementation of Association Rule Mining for Network Intrusion Detection
Ninja: Towards Transparent Tracing and Debugging on ARM.